Treatment of malignant pericardial effusion with 32P-colloid
Author Information
Author(s): Dempke W, Firusian N
Primary Institution: Department of Internal Medicine IV, Martin-Luther-University Halle-Wittenberg
Hypothesis
The study aims to evaluate the efficacy of intrapericardial 32P-colloid in terms of response rates and duration of remissions.
Conclusion
Intrapericardial instillation of 32P-colloid is a simple, reliable, and safe treatment strategy for patients with malignant pericardial effusions.
Supporting Evidence
- Intrapericardial 32P-colloid resulted in a complete remission rate of 94.5% in patients.
- The median duration of remission was 8 months.
- No side effects were observed with the treatment.
Takeaway
Doctors can use a special treatment called 32P-colloid to help patients with a serious heart fluid problem, and it works really well.
Methodology
Intrapericardial instillation of 185–370 MBq (5–10 mCi) 32P-colloid was performed on patients with malignant pericardial effusion.
Limitations
Two patients did not respond to treatment due to rapid formation of pericardial fluid.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website